Inception Fund is a Seattle based venture capital firm focused on cancer biotechnology and late-stage, brand name technology companies. They believe that they are in the Golden Age of Biotech and some of the greatest advancements in technology and discovery will be found in the life sciences. The advancement of biotechnology in the next couple of decades will be instrumental in saving millions of lives.
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.